Cart
sales@molnova.com
MDK-4025
CAS No. 66774-02-5
MDK-4025( —— )
Catalog No. M22640 CAS No. 66774-02-5
MDK-4025 is an inhibitor of the high voltage-activated (HVA) Ca2+ current in pyramidal neurons.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 177 | In Stock |
|
| 5MG | 267 | In Stock |
|
| 10MG | 408 | In Stock |
|
| 25MG | 672 | In Stock |
|
| 50MG | 945 | In Stock |
|
| 100MG | 1278 | In Stock |
|
| 500MG | 2547 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMDK-4025
-
NoteResearch use only, not for human use.
-
Brief DescriptionMDK-4025 is an inhibitor of the high voltage-activated (HVA) Ca2+ current in pyramidal neurons.
-
DescriptionMDK-4025 is an inhibitor of the high voltage-activated (HVA) Ca2+ current in pyramidal neurons.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number66774-02-5
-
Formula Weight294.78
-
Molecular FormulaC19H15ClO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(c1ccccc1)(c1ccccc1)c1ccccc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.M M Shah , Z Miscony, M Javadzadeh-Tabatabaie, C R Ganellin, D G Haylett,et al.Clotrimazole analogues: effective blockers of the slow afterhyperpolarization in cultured rat hippocampal pyramidal neurones.Br J Pharmacol. 2001 Feb;132(4):889-98.
molnova catalog
related products
-
Zonisamide
Zonisamide is a sulfonamide anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures.
-
AMG1
A novel specific CRAC channel inhibitor that blocks function of effector.
-
JTV-519 fumarate
JTV-519 (K201) is a Ca2+-dependent blocker of SERCA and a partial agonist of ryanodine receptors (RyRs).
